[Treatment of stage-I seminoma. Critical review].
Santini
D
D
Università degli Studi di Roma La Sapienza, Roma Servizio Speciale Diagnostica e Programmazione Terapeutica.
Simeoni
F
F
Bianco
V
V
Chiodini
S
S
Speranza
I
I
Pignatelli
E
E
Marchei
P
P
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009919:Orchiectomy; D011832:Radiation Injuries / Q000209:etiology; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects / Q000379:methods; D012186:Retroperitoneal Neoplasms / Q000175:diagnosis / Q000556:secondary; D012189:Retrospective Studies; D012307:Risk Factors; D018239:Seminoma / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology / Q000556:secondary / Q000628:therapy*; D013736:Testicular Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*
D003520:Cyclophosphamide; D002945:Cisplatin
Terapia del seminoma I stadio. Revisione critica.